CEL-SCI Corp (CVM) - Hot Corp. News

CEL-SCI Corp (CVM) – Hot Corp. News

Jun 28, 2021 09:21 AM CEL-SCI Corp (CVM) Multikine Immunotherapy Produces Significant 14.1% 5-Year Survival Benefit in the Group Receiving Surgery Plus Radiotherapy in a Landmark Head and Neck Cancer Phase 3 Study
Feb 26, 2020 03:19 PM CEL-SCI Corp (CVM) Issues Letter to Shareholders
Jan 3, 2018 07:33 AM
Dec 11, 2017 01:31 PM
Aug 23, 2017 09:02 AM
Aug 14, 2017 07:01 AM
Nov 21, 2016 08:31 AM
Oct 21, 2016 08:03 AM
Sep 27, 2016 06:37 AM
Sep 6, 2016 08:33 AM
Jan 2, 2014 10:35 AM